2006
  1. Groll,M., Gotz,M., Kaiser,M., Weyher,E. and Moroder,L.
    TMC-95-Based inhibitor design provides evidence for the catalytic versatility of the proteasome
    Chem Biol13, 607-614. PubMed  Europe PubMed DOI  I